Aloxistatin

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameAloxistatin
Drug Alias NameLoxistatinRexostatineEstateE-64-d
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFalcipain 2 inhibitorsCalpain1/2 inhibitorsCathepsin B inhibitors +[4] 
TargetsCathepsin LFalcipain 2Cathepsin B +[4] 
Therapy Area/IndicationsMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponTaisho Pharmaceutical Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophies

Other Information

ATC CodeN/A
Related LinksN/A